chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient became very short of breath several minutes after immunization.  911 was called upon patients request, but soon prior to their arrival patient symptoms started to improve.  Paramedics quickly took over, started doing patient work-up, and shortly after escorted patient out of the store.
Swelling, redness, itching.  Advised home care ice and antihistamines.
One week post vaccination, became uncomfortable with severe itching around front and right side of waist. Skin appears normal.
Hard sore & hot lump entire upper left arm, and very hard and sore armpit with enlarged lymph nodes. Only reporting as it has now been 3 days still painful. Also had flu like symptoms sore stiff back & neck with chills next day.
weak; dizziness; She also stated that she took her blood pressure at home, the first reading was high and now its low; This is a spontaneous report from a contactable Consumer (Patient's husband).  A 67 years-old female patient received first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection), via an unspecified route of administration on 29Jan2021, as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 03Feb2021, the patient experienced dizziness which is unusual for her and she took her blood pressure at home, the first reading was high and now its low. She stated that she was supposed to take her husband to an appointment, today, but when she stood up to reach something on a tall shelf she felt dizzy and weak. She has since been taking it easy today and drinking plenty of water.  the patient wants to know how long symptoms typically last.  Caller also mentioned that her husband had recently tested positive for COVID, but completed his quarantine. On an unspecified date the patient experienced weak. All the events were non-serious. Duration for injection site reactions are reported as 2.5days, but patients were asked to reports symptoms for 7-days post-dose.  Lot/batch number was not obtained. Follow-up attempts are completed; information about lot/batch number was not obtained.
A fast heartbeat- Dizziness, and weakness; Numbness and tingling; The muscles of my fingers went stiff, where my thumbs couldn?t move away from my inner palms and my other fingers would not bend. I also had difficulty speaking, as if my tongue was numb or hard to move.  This lasted about an hour (15 hrs post-vaccine).
Patient is a 4yo male presenting with suspected anaphylactic shock after MMR vaccination at the primary care physician's office. He was at the pediatrician's office today and received MMR-varicella, Hepatitis A vaccine, and DTaP-Polio vaccinations, almost immediately he began to feel itchy, he became flushed and erupted in hives. At that point he was not talking so mom picked him up and started to talk to him. While in mom's arms he told mom he felt nauseated and then vomited. Then he became limp and unresponsive and mom noted that he was not breathing and cyanotic. Epinephrine was immediately administered by Epipen Jr twice, 15 min apart and the patient resumed breathing and became more responsive. At this point the patient had repeated emesis and was suctioned. Albuterol was also administered at this time as the patient has a history of asthma and someone in the pediatrician's office reported hearing wheezing. He was placed on 100% oxygen by NRM, given Benadryl and Solumedrol IV and transported to the Emergency Dept. Here he was found to be hypotensive and given fluids to bolster pressures. He was still very flushed, had increased edema of the cheeks and lips, but no visible edema of the tongue or airway, no abnormal breath sounds and no increased work of breathing. He was started on IV Zantac, given 40mL/kg IVF for hypotension and admitted to the Pediatric ICU for close monitoring.
Tingling in contralateral shoulder and right side of neck began a couple days after injection and continued.  After the second vaccination (11/14/21, lot FE3590) in the same shoulder, the tingling spread across through (and higher up) neck to left shoulder and persisting to this day. Pt mentioned this during visit today, it was not the cause of today's visit.
Erratic heart beat; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: lot number: Elo140), via an unspecified route of administration on left arm on 11Jan2021 13:00 (first dose) at a single dose for COVID-19 immunization. The patient medical history was not reported. The patient is not pregnant at the time of vaccination. No other vaccine in four weeks. Patient had no COVID prior vaccination and no known allergies. Concomitant medications included other medication (taken other medication in two weeks). The patient experienced erratic heart beat on 11Jan2021 14:00. The event resulted in doctor or other healthcare professional office/clinic visit. There was no treatment for the event. The patient was not COVID tested post vaccination. The outcome of the event was not recovered.
This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine which underwent temperature excursion started on 21-Feb-2023), PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent Vaccine underwent temperature excursion started on 21Feb2023) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 214K22A) for COVID-19 prophylaxis.     No Medical History information was reported.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021 at 11:05 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 11:02 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 03-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Vial was moved to fridge on 24-Feb-2021. Product moved to clinic on 03-Mar-2021. Batch number 014M20A underwent temperature excursion on 03-Mar-2021 with temperature 52 degrees Fahrenheit at 9 AM, 34 degrees Fahrenheit at 10 AM and 35 Degrees Fahrenheit at 1 pm. Beyond use date for the vial was reported as 26-Mar-2021.  Vial was moved to fridge on 30-Mar-2021. Batch number 030B21A underwent temperature excursion on 31-Mar-2021 with temperature 32 degrees Fahrenheit from 8AM to 9AM. Product moved to clinic on 31-Mar-2021. Beyond use date for the vial was reported as 29-Apr-2021.   Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Contacted poison ivy two months later; Shingles with rash and pain from shoulder blade to the elbow; This spontaneous report was received from a 65-year-old female patient referring to herself. The patient's medical history, concurrent conditions, drug allergies or reactions and concomitant therapy were not provided.      On an unspecified date in 2014, the patient was vaccinated with initial dose of zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, frequency and anatomical location were not provided), route of administration reported as injection for prevention of shingles (prophylaxis). On an unspecified date (reported as two months later), the patient got contacted with poison ivy (exposure to toxic agent) and 4 months after the initial zoster vaccine live (ZOSTAVAX) injection, she experienced shingles with rash and pain from shoulder blade to the elbow (herpes zoster). She sought medical attention from the physician's office and was prescribed with an unspecified medication for treatment. The patient declined to participate fully and to provide full demographics. No further symptoms or specifics were provided. Product quality complaint (PQC) was not associated with this report. The patient was not sure how long the events lasted, but on an unknown date, the events were recovered eventually. The causality assessment was not provided by the reporter.
HOT FLASHES; FELT LIKE 'CRAP'; NAUSEA; HEADACHES OR MIGRAINES; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had severe allergies to many substances so had to have the vaccine administered by allergy specialist. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 22-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On JUN-2021, Laboratory data included: Body temperature (NR: not provided) slightly elevated but no fever. On 22-JUN-2021, the patient experienced flu like symptoms. On 23-JUN-2021, the patient experienced headaches or migraines. On 23-JUN-2021, the patient experienced felt like 'crap'. On 23-JUN-2021, the patient experienced nausea. On 24-JUN-2021, the patient experienced hot flashes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, was recovering from hot flashes, flu like symptoms, and felt like 'crap', and had not recovered from headaches or migraines. This report was non-serious. This case, from the same reporter is linked to 20211124550.
Eye mucous blurring vision with peri-orbital swelling andcreddened swelling bilaterally approximately 5 hours post injection, followed by chilling with uncontrollable shivering approximately 1 hour later. Then symptoms of a swollen tender lump in throat with did not impede breathing or swallowing just after the chilling. Later with 3 episodes of mild diarrhea approximately 9, 11 and 12 hours s/p vaccine.
Patient received a dose of vaccine that was stored under refrigeration for longer than the recommended 30 days. Product was received and placed in the refrigerator on 4/13/21 and dose given on 4/25/21, 12 days beyond the use date. Moderna was contacted, but no further stability data given, or any recommendations. Press releases from the end of April show that Moderna has shown the vaccine to be stable under refrigeration for 90 days. Patient was notified, and pharmacists did not recommend a repeat dose.
She's had some issues come up with her heart and she has heard that heart issues are being noted with the vaccine.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was having some side effects and she was under a doctors care and she knew she needs to report her side effects. She was asking what kind of information she needed to provide for reporting her side effects. She did not see her doctor again until this Friday, 10Sep2021 and she did not know if her doctor should be the one reporting. On an unspecified date, she had some issues came up with her heart and she has heard that heart issues are being noted with the vaccine. She thought this was serious enough to mention. It was reported that she will see her doctor again on Friday (on reporting date) and she'll have more information to provide like the results of her EKG and echocardiogram. Before filing a safety report, she would like to speak to her doctor and get more information regarding her test results and medical information. The patient underwent lab tests and procedures which included echocardiogram and electrocardiogram with unknown results performed on an unspecified date. Outcome of the event was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
blood pressure went up so high.; This spontaneous case was reported by an other health care professional and describes the occurrence of BLOOD PRESSURE INCREASED (blood pressure went up so high.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Irritable bowel syndrome.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced BLOOD PRESSURE INCREASED (blood pressure went up so high.) (seriousness criterion hospitalization). At the time of the report, BLOOD PRESSURE INCREASED (blood pressure went up so high.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Blood pressure measurement: high (High) high.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.  Company Comment - This is a spontaneous case concerning a 65-year-old female patient with no reported medical history, who experienced the serious (hospitalization)  unexpected event Blood pressure increased. The event occurred one day after the second  dose of mRNA-1273.  Limited information has been  provided, further information has been requested.  The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2021-388714. Sender's Comments: This is a spontaneous case concerning a 65-year-old female patient with no reported medical history, who experienced the serious (hospitalization)  unexpected event Blood pressure increased. The event occurred one day after the second  dose of mRNA-1273.  Limited information has been  provided, further information has been requested.  The benefit-risk relationship of mRNA-1273 is not affected by this report.
The first day of the side effect my arm was swollen about 2 inches long, red and hot. The next day it spread into a square shape, the swelling went down and it itched. It was still red and hot. Day 3 it was still sore, but that is all. It's not red or swollen.
Fever 24 hours, 103 F. No specific treated with Tylenol.
Red lump, red streaks, excessive sleepiness sore arm. Came in for office visit 10/09/18.
Pt cried unconsolably x 4 days; refused to eat & had difficulty sleeping; high pitched screaming x 4 days;
Diagnosed with shingle; Rash on the Left eye; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Diagnosed with shingle) and RASH (Rash on the Left eye) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RIVAROXABAN (XARELTO), LEVOTHYROXINE, HYDROBROMIDE DEXTROMETHORPHAN, ATENOLOL, NIFEDIPINE (SELCA), PREGABALIN (LYRICA), SOTALOL, POTASSIUM CHLORIDE, LATANOPROST and ALENDRONATE SODIUM (ALENDRONATO) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced HERPES ZOSTER (Diagnosed with shingle) and RASH (Rash on the Left eye). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Antiviral treatment, at a dose of 100 milligram. At the time of the report, HERPES ZOSTER (Diagnosed with shingle) outcome was unknown and RASH (Rash on the Left eye) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient complained about 4 hours after vaccine administration with significant pain in shoulder, pain worse than typical soreness, patient stated will be going to ER for evaluation, administering pharmacist said patient was moving and flexing muscle at time of administration.
Chirping sound twice in ears , like crickets, after first dose.  A few days after second dose, tinnitus and noises in head very loud at times, and became constant.  Loudness of sounds more constant now.
At onset headache and arm pain. One week after vaccine, chest and headache. Elevated blood pressure. Went to ER to rule out heart attack.  Currently day 10 of the acute symptoms. They have gotten less but still occur many times throughout the day.
pt reported a fever of 99.0F and lethargy/ being tired mor than usualy the next morning after the shot
This spontaneous report as received from the treating physician's staff secretary via a company representative referred to a patient (age not reported) who in 2013 was vaccinated with a dose of ZOSTAVAX (dose not reported), subcutaneous injection for prevention of shingles. In 2013 the patient developed swelling at injection site after receiving ZOSTAVAX, that was tender to the touch. On an unknown date the patient developed rash and went to first urgent care for treatment. At the time of the report the patient recovered from swelling at injection site, tender to touch. Relationship between swelling at injection site, tender to touch, rash and therapy with ZOSTAVAX was not reported. It was not known if the patient "received the ZOSTAVAX some time last week or some time this week" and it was also not known if this report corresponds to the "male or female patient". This is one of several reports from the same reporter. Additional information has been requested.
PATIENT COMPLAIN SORENESS AT THE SITE OF INJECTION RADIATING TO THE INJECTED ARM.
Persistent fever to 103 rectally for 2 days. Decreased activity, mild dehydration. Admitted for IV fluids and septic work up. The discharge summary states aseptic meningitis. 60-day follow up on 11/26/2003: "Vaccine recipient has recovered from the adverse events that were reported for this vaccination. "
I belive this injection caused my daughter's death; This spontaneous report was received from the patient's father via social media, referring to a female patient of unknown age. The patient's medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with unspecified human papillomavirus (HPV) vaccine (manufacturer unknown), dosage, route, lot# and expiration date were not provided. Concomitant therapies were not reported. The patient's father stated that "he believed this injection caused his daughter death, the date of the patient's death was not provided, It was unknown if an autopsy was done. The outcome of the event was fatal. Additional information has been requested.
1-2 days fever followed by malaise x 5d then onset of a rash over forehead over 24hr-chest & abd by date of exam 1MAY97;no URI;c/o sl dec appetite, rash morbilliform, blanching pt did not appear ill;
diarrhea; stomach pain/pains in her stomach; loss of appetite; generally feeling unwell; Tiredness/been tired; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 30Jan2021 15:00 at single dose (right arm) for COVID-19 immunization. Medical history included ulcerative colitis diagnosed 14 years ago. Concomitant medication included budesonide (UCERIS) for ulcerative colitis from Jan2021. On 01Feb2021, the patient experienced stomach pain/pains in her stomach, loss of appetite, been tired, and had a headache. She was generally feeling unwell and was asking if these were common side effects of the vaccine. On an unspecified date, she started having diarrhea. She says she doesn't know if these could be side effects, she also has ulcerative colitis. She has already checked out a website and she would like more information about whether this was something she should ride out, or how long it might last. She does not currently have her vaccine card with her to provide lot information for this product. She says she has had no other recent vaccination in the last 6-8 weeks, though she started a new medication in Jan2021 for her ulcerative colitis. She reported that she has not treated her headache, stomach pains, or diarrhea yet. She says that the possible side effects started yesterday (as reported), she would say that they have gotten worse as she was really tired, and it has gotten more noticeable. She says she had nothing on Saturday or Sunday, these things started yesterday afternoon (01Feb2021). Outcome of events was unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from an office manager refers to a patient of unknown age who on 28-SEP-2012, was vaccinated with a dose of RECOMBIVAX HB (lot number 671326/1522AA) (dose and route not reported) that was improperly stored. No symptoms reported. This is one of several reports from the same source. Additional information has been requested.
Pt says left arm feels heavy and it aches. It feels tired. Mom says she has been saying this ever since she received the shot.
Patient came into public health clinic on 3/27/2015 to receive a print out of a flu shot that was administered by our office on 1/20/2014.  Patient reported he developed left arm and shoulder weakness, pain and loss of motion after receiving the flu shot and had been diagnosed with Parsonage-Turner Syndrome.  He reported this occurred after getting the vaccination and he was unable to work for several weeks and required physical therapy.  He reports he is still unable to have full range of motion of his left arm/shoulder.  Unknown if a previous VAERS report has been filed.
2 days after 1st vaccine I developed ringing in my ears with loss of hearing, inability to process thoughts properly.